Quantcast Healthcare Park To Be Built In Suzhou, China
Search by tag or site Login to my blog ? Start my own blog














TheMoneyBlogs
Home
About
Create your own blog
Contact us
Vote for this blog!

BioHealth Investor

BioHealth Investor (BHI) is a blog and journal focused on providing updated commentary and financial news from the biotech and medical technology industry. BHI's content is featured on Yahoo!Finance, Google Finance, TheStreet.com, SeekingAlpha.com and many other blogs and websites. BHI is also a proud member of The Business of Biotech Network, and the Investors Blog Network.

Healthcare Park To Be Built In Suzhou, China

Posted on 06/27/2007 06:04:29 | Link | Post Comment
by Richard Daverman, PhD
ChinaBio Today



Will Be Largest in China

The Suzhou International Healthcare Park Co. Ltd. is set to begin construction of the largest healthcare park in China, covering 200 hectares in the Wujiang Industrial Development Zone just outside of Suzhou.

Suzhou is a 45-minute train ride from Shanghai.

The company expects to spend 16 billion yuan ($2.1 billion) over the next three years to build facilities that will produce healthcare products.

The company has signed an agreement with the management committee of the industrial zone, leasing the land.

In the first phase of development, 700 million yuan ($92 million) will be spent to construct facilities over one-quarter of the space, 50 hectares. In the remaining space, standardized units will be built and leased to healthcare producers. All facilities are expected to be completed within three years.

The construction will be financed by a consortium of five banks. Other funding will come from foreign investors. So far, ten investors from Japan, the US and other countries have signed letters of intent with the company to produce healthcare products in the park.

Wujiang is a small city under Suzhou's jurisdiction. It currently has three main industries: textiles, telecommunications and IT. The healthcare initiative is aimed at diversifying this base.



RELATED READING:
- China Biotech Weekly Review: TCM Goes Mainstream
- China Biopharma Strikes Deal for Antiviral
- China Meditech Pays $3.3 Million for R&D Facility



ChinaBio Today is a regular contributor to BioHealth Investor
_____________
Stock Quote or
Examples
Morpheus Trading - Thu Jul 17, 2008 01:15AM
NOTE: Please click on the charts below to enlarge them if th [read more]
Morpheus Trading - Mon Jul 21, 2008 08:33AM
NOTE: Please click on the charts below to enlarge them if [read more]
The Swing of Things - Thu Jul 17, 2008 09:36AM
I used to make a pretty good living sharing hard won [read more]

PREMIER SPONSORED LINKS

Most Visited Blogs | Most Popular Blogs | Most Recent Blogs | Contact Us | Terms and conditions | Privacy Policy

The columns, articles, message board posts and any other features provided on TheMoneyBlogs.com are provided for personal finance, education and investment information and are not to be construed as investment advice. Under no circumstances does the information in this content represent a recommendation to buy, sell or hold any security. The views and opinions expressed in an article or column are the author's own and not necessarily those of TheMoneyBlogs.com and there is no implied endorsement by TheMoneyBlogs.com of any advice or trading strategy. The analysts and employees or affiliates of TheMoneyBlogs.com may hold positions in the stocks or industries discussed here. Your use of this and all information contained on TheMoneyBlogs.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

Copyright © 2008 The Connors Group, Inc.